These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 21282015

  • 1. Cytokeratin 7 and cytokeratin 20 expression in colorectal adenocarcinomas.
    Bayrak R, Yenidünya S, Haltas H.
    Pathol Res Pract; 2011 Mar 15; 207(3):156-60. PubMed ID: 21282015
    [Abstract] [Full Text] [Related]

  • 2. Expression of cytokeratins 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas to the ovary.
    Park SY, Kim HS, Hong EK, Kim WH.
    Hum Pathol; 2002 Nov 15; 33(11):1078-85. PubMed ID: 12454811
    [Abstract] [Full Text] [Related]

  • 3. Use of caveolin-1, thyroid transcription factor-1, and cytokeratins 7 and 20 in discriminating between primary and secondary pulmonary adenocarcinoma from breast or colonic origin.
    Tsao SC, Su YC, Wang SL, Chai CY.
    Kaohsiung J Med Sci; 2007 Jul 15; 23(7):325-31. PubMed ID: 17606426
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Role of TTF-1, CK20, and CK7 immunohistochemistry for diagnosis of primary and secondary lung adenocarcinoma.
    Su YC, Hsu YC, Chai CY.
    Kaohsiung J Med Sci; 2006 Jan 15; 22(1):14-9. PubMed ID: 16570563
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Value of cytokeratin 7 and 20 for the diagnosis of cerebral metastases of adenocarcinoma: study of 78 cases].
    Fernandez C, Liprandi A, Bouvier-Labit C, Figarella-Branger D.
    Ann Pathol; 2001 Apr 15; 21(2):129-35. PubMed ID: 11373582
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.
    Chhieng DC, Cangiarella JF, Zakowski MF, Goswami S, Cohen JM, Yee HT.
    Cancer; 2001 Oct 25; 93(5):330-6. PubMed ID: 11668468
    [Abstract] [Full Text] [Related]

  • 12. The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody.
    Bayrak R, Haltas H, Yenidunya S.
    Diagn Pathol; 2012 Jan 23; 7():9. PubMed ID: 22268990
    [Abstract] [Full Text] [Related]

  • 13. Combined immunohistochemistry of beta-catenin, cytokeratin 7, and cytokeratin 20 is useful in discriminating primary lung adenocarcinomas from metastatic colorectal cancer.
    Ikeda S, Fujimori M, Shibata S, Okajima M, Ishizaki Y, Kurihara T, Miyata Y, Iseki M, Shimizu Y, Tokumoto N, Ozaki S, Asahara T.
    BMC Cancer; 2006 Feb 02; 6():31. PubMed ID: 16451736
    [Abstract] [Full Text] [Related]

  • 14. Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors.
    Cai YC, Banner B, Glickman J, Odze RD.
    Hum Pathol; 2001 Oct 02; 32(10):1087-93. PubMed ID: 11679943
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Aberrant cytokeratin expression as a possible prognostic predictor in poorly differentiated colorectal carcinoma.
    Yamagishi H, Imai Y, Okamura T, Fukuda K, Ono Y, Ban S, Inoue T, Ueda Y.
    J Gastroenterol Hepatol; 2013 Dec 02; 28(12):1815-22. PubMed ID: 23808938
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The value of cytokeratins 20 and 7 in discriminating metastatic adenocarcinomas from pleural mesotheliomas.
    Tot T.
    Cancer; 2001 Nov 15; 92(10):2727-32. PubMed ID: 11745209
    [Abstract] [Full Text] [Related]

  • 19. Cytokeratin expression profiling in gastric carcinoma: clinicopathologic significance and comparison with tumor-associated molecules.
    Takami H, Sentani K, Matsuda M, Oue N, Sakamoto N, Yasui W.
    Pathobiology; 2012 Nov 15; 79(3):154-61. PubMed ID: 22286119
    [Abstract] [Full Text] [Related]

  • 20. Five commonly used markers (p53, TTF1, CK7, CK20, and CK34betaE12) are of no use in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray extension study.
    Han CP, Kok LF, Lee MY, Wu TS, Ruan A, Cheng YW, Wang PH, Koo CL, Tyan YS.
    Arch Gynecol Obstet; 2010 Feb 15; 281(2):317-23. PubMed ID: 19444461
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.